Postnatal choline levels mediate cognitive deficits in a rat model of schizophrenia.
In the present study, we investigated whether the essential nutrient choline may protect against schizophrenic-like cognitive deficits in a rat model. Theories regarding the etiology of schizophrenia suggest that early life events render an individual more vulnerable to adult challenges, and the combination may precipitate disease onset. To model this, the adult male offspring of dams who either experienced stress during late gestation or did not were given a 5 mg/kg dose of the NMDA antagonist,MK-801. The presence of both the prenatal challenge of stress and the adult challenge of MK-801 was expected to impair memory in these offspring. Memory was not expected to be impaired in rats that did not experience prenatal stress, but did receive MK-801 as adults. To study whether choline levels altered outcomes in these groups, rats were fed a choline-supplemented, -deficient, or standard diet during the period between the two challenges: beginning at weaning and continuing for 25 days. All rats consumed regular rat chow thereafter. The efficacy of the model was confirmed in the standard fed rats in that only those that were prenatally stressed and received MK-801 as adults displayed impaired memory on a novelty preference test of object recognition. Contrary to this finding and consistent with our hypothesis, choline-supplemented rats that were also both prenatally stressed and given MK-801 as adults showed intact memory. Choline deficiency impaired memory in rats that were just prenatally stressed, just given MK-801 as adults, and subjected to both. Thus, a choline deficient diet may render rats vulnerable to either challenge. Taken together, we offer evidence that developmental choline levels modulate the effects of prenatal stress and/or MK-801 and thereby alter the cognitive outcome in a rat model of schizophrenia.
Department of Psychology, Colby College, Waterville, ME 04901, USA.
Jennifer A
JA
Corriveau
Melissa J
MJ
Glenn
D000818:Animals; D002794:Choline / Q000008:administration & dosage / Q000378:metabolism*; D002796:Choline Deficiency / Q000523:psychology; D003072:Cognition Disorders / Q000209:etiology / Q000378:metabolism*; D004195:Disease Models, Animal; D016291:Dizocilpine Maleate / Q000008:administration & dosage; D004435:Eating / Q000187:drug effects / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage; D005106:Exploratory Behavior / Q000502:physiology; D005260:Female; D008297:Male; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000378:metabolism / Q000523:psychology; D051381:Rats; D020318:Rats, Long-Evans; D012559:Schizophrenia / Q000209:etiology / Q000378:metabolism*; D012565:Schizophrenic Psychology; D013312:Stress, Physiological
D018691:Excitatory Amino Acid Antagonists; D016291:Dizocilpine Maleate; D002794:Choline